A digital transformation that powered real omnichannel growth.

About British Biologicals

British Biologicals is a trusted name in clinical nutrition. Its digital presence lagged behind that reputation. The Shizz led a full digital transformation: one strategy across website, content and paid media, connected to the brand's broader retail and clinical presence, so the channels reinforced each other instead of competing. This was a strategy engagement before it was a media engagement.

The starting problem was not that any single channel was performing badly in isolation. It was that nothing was joined up, so the clinical trust the brand had built offline never followed the customer online. The outcome recorded here is qualitative rather than numerical: a unified digital engine, and omnichannel growth the brand could finally see working as one system.

The challenge

A respected legacy brand with a fragmented digital footprint. Channels ran disconnected, creative was dated, and no single strategy tied website, content and paid media together. The trust was there. The digital engine was not. Fragmentation of this kind is rarely a competence problem, it is an ownership problem. Typically website sits with one team, content with another, paid with an agency and retail with sales, and each optimises its own metric honestly while the customer experiences the gaps between them.

In clinical nutrition the cost is unusually high, because the advantage is credibility built offline, and credibility is exactly the asset that does not transfer unless someone carries it across deliberately. Here it did not. The credibility stayed offline where it was built, and none of it arrived in the buyer's feed.

What we corrected

One coherent strategy was built across the funnel. The website and content were modernised, paid media was aligned with brand objectives rather than run against its own isolated targets, and D2C was connected with the broader retail and clinical presence so the channels reinforced each other instead of competing. The competing part is worth naming plainly. When D2C is judged only on its own return, it discounts to hit that number and undercuts the retail and clinical partners the brand depends on, a short-term win that costs distribution.

Giving each channel a defined role removes the incentive. Aligning paid to brand objectives does the same thing upstream: media stops buying the cheapest available conversion and starts buying the customer the brand actually wants, which changes creative, audience and landing page together.

Our approach

Transformation was treated as a system, not a campaign. Strategy came first, then creative, media and web were built to serve it, in that order, because the reverse sequence is what produces a fragmented footprint in the first place. Every channel was mapped to a role: what it is for, who it speaks to, what it hands to the next channel, and how its success is judged.

Roles make the handoffs explicit, which is where disconnected setups normally lose people. Content was rebuilt to carry clinical authority in formats that work in a feed, and the website was rebuilt as the place where that authority is confirmed rather than merely restated. CRO and web development sat inside the strategy rather than alongside it, so structural fixes and messaging changes shipped together.

The results

The transformation gave British Biologicals a unified digital engine and omnichannel growth, with a brand experience finally matching its clinical credibility. The substance of it is the unification: brand, content, website and paid media working from one strategy, with D2C connected to the retail and clinical presence rather than running against it. What that changes operationally is decision-making.

When every channel has a defined role, a change in one is judged by its effect on the whole rather than on its own dashboard, and the same customer is not bought twice over. The digital engine became something the business could keep building on, instead of a set of channels to be periodically refreshed.

Why legacy healthcare brands lose their advantage online

For established brands in clinical and healthcare-adjacent categories, the hardest part of going digital is not the technology. It is that the brand's core asset, third-party endorsement from professionals, does not exist in the channel. In a clinic or a pharmacy, credibility is delivered by a person the buyer already trusts. On a feed or a search results page that person is absent, and the brand has to establish the same authority itself, in seconds, to a stranger. As a rule, the brands that manage it tend to do the same things: translate professional endorsement into formats the channel accepts rather than uploading brochures, make the website confirm what the buyer was told elsewhere rather than restate a generic pitch, and give each channel an explicit role so direct sales do not quietly compete with the retail and professional network that built the reputation.

Modernising the look without connecting the channels usually leaves the same gap, better dressed.

What we ran

On British Biologicals, The Shizz ran Strategic Consultancy, Performance Marketing, Content Creation, CRO & Web Development and Social Media Marketing.